ANIX - CIK 0000715446
Anixa Biosciences Inc has filed 960 documents with the SEC between 1995 and 2026. The most frequent type is insider trade (415 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2021-06-10 | 2021-04-30 |
| Activist ownership stake (update) | SC 13D/A | 2021-06-10 | - |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-05-31 |
| Major company event | 8-K | 2021-05-27 | 2021-05-21 |
| Insider trade | 4 | 2021-05-04 | 2021-04-30 |
| Insider trade | 4 | 2021-04-23 | 2021-04-23 |
| Insider trade | 4 | 2021-04-20 | 2021-04-20 |
| Insider trade | 4 | 2021-04-20 | 2021-04-19 |
| Proxy statement | DEF 14A | 2021-04-09 | 2021-04-09 |
| Major company event | 8-K | 2021-04-02 | 2021-03-29 |
| PRE 14A | - | 2021-03-30 | 2021-03-30 |
| Insider trade | 4 | 2021-03-26 | 2021-03-25 |
| Insider trade | 4 | 2021-03-26 | 2021-03-25 |
| Insider trade | 4 | 2021-03-25 | 2021-03-25 |
| Insider trade | 4 | 2021-03-25 | 2021-03-25 |
| Major company event | 8-K | 2021-03-24 | 2021-03-22 |
| Prospectus supplement | 424B5 | 2021-03-24 | - |
| Free writing prospectus | FWP | 2021-03-23 | - |
| Free writing prospectus | FWP | 2021-03-22 | - |
| Prospectus supplement | 424B5 | 2021-03-22 | - |
| Quarterly report | 10-Q | 2021-03-11 | 2021-01-31 |
| Activist ownership stake (update) | SC 13D/A | 2021-02-05 | - |
| Insider trade | 4 | 2021-02-05 | 2021-02-03 |
| Insider trade | 4 | 2021-02-01 | 2021-01-29 |
| Major company event | 8-K | 2021-01-28 | 2021-01-26 |
| Employee stock plan | S-8 | 2021-01-07 | - |
| Annual report | 10-K | 2021-01-07 | 2020-10-31 |
| Insider trade | 4 | 2020-12-28 | 2020-12-23 |
| Insider trade | 4 | 2020-12-28 | 2020-12-23 |
| Major company event | 8-K | 2020-12-01 | 2020-11-30 |
| Insider trade | 4 | 2020-11-03 | 2020-10-31 |
| Major company event | 8-K | 2020-09-16 | 2020-09-16 |
| Insider trade | 4 | 2020-09-14 | 2020-09-11 |
| Insider trade | 4 | 2020-09-11 | 2020-09-11 |
| Quarterly report | 10-Q | 2020-09-08 | 2020-07-31 |
| Insider trade | 4 | 2020-08-17 | 2020-08-13 |
| Insider trade | 4 | 2020-08-17 | 2020-08-13 |
| Insider trade | 4 | 2020-08-17 | 2020-08-13 |
| Insider trade | 4 | 2020-08-17 | 2020-08-13 |
| Insider trade | 4 | 2020-08-17 | 2020-08-13 |
| Major company event | 8-K | 2020-08-17 | 2020-08-13 |
| Proxy materials | DEFA14A | 2020-07-20 | - |
| Proxy statement | DEF 14A | 2020-07-02 | 2020-07-02 |
| Major company event | 8-K | 2020-07-02 | 2020-07-02 |
| PRE 14A | - | 2020-06-22 | 2020-06-22 |
| Insider trade | 4 | 2020-06-17 | 2020-06-16 |